Cours Cantabio Pharmaceuticals Inc. Other OTC
Actions
CTBO
US13808X2036
Recherche biotechnologique et médicale
CA 2017 | - | CA 2018 | - | Capitalisation | 2,36 M 2,11 M |
---|---|---|---|---|---|
Résultat net 2017 | -1 M -896 k | Résultat net 2018 | -2 M -1,79 M | VE / CA 2017 | - |
Dette nette 2017 | 337 k 302 k | Dette nette 2018 | 1,1 M 981 k | VE / CA 2018 | - |
PER 2017 * |
-
| PER 2018 |
-
| Employés | - |
Rendement 2017 * |
-
| Rendement 2018 |
-
| Flottant | 29,99% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+51,85% | 57,87 Md | |
+41,42% | 40,25 Md | |
-5,25% | 39,94 Md | |
-5,16% | 28,54 Md | |
+12,79% | 26,4 Md | |
-20,18% | 19,33 Md | |
+30,88% | 12,4 Md | |
+0,61% | 12,23 Md | |
+25,06% | 12,2 Md |